Do helminths cause epilepsy?

Parasite Immunology

Volumn 31, Issue 11, 2009, Pages 697-705

  Wagner, R G ^a   Newton, C R ^b,c,d,e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Wolfson Centre   (United Kingdom)

Author keywords

Burden; Epilepsy; Helminths; Pathogenesis; Seizures

Indexed keywords

CYTOKINE;

ANGIOSTRONGYLUS CANTONENSIS; CESTODE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EPILEPSY; EPILEPTOGENESIS; GEOGRAPHIC DISTRIBUTION; HELMINTHIASIS; HUMAN; INCIDENCE; INFLAMMATION; NEMATODE; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRONGYLOIDES STERCORALIS; TH2 CELL; TOXOCARA; TREMATODE;

ANIMALS; CENTRAL NERVOUS SYSTEM; EPILEPSY; HELMINTHIASIS; HELMINTHS; HOST-PARASITE INTERACTIONS; HUMANS; VIRULENCE;

VERMES;

EID: 70349970149     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01128.x     Document Type: Review

References (75)

1. Garcia HH Modi M. Helminthic parasites and seizures. Epilepsia 2008 49 : 25 32.
2. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest 2008 118 : 1311 1321.
3. Parraga IM, Assis AM, Prado MS, et al. Gender differences in growth of school-aged children with schistosomiasis and geohelminth infection. Am J Trop Med Hyg 1996 55 : 150 156.
4. Jallon P. Epilepsy in developing countries. Epilepsia 1997 38 : 1143 1151.
5. MacDonald AS, Araujo MI Pearce EJ. Immunology of parasitic helminth infections. Infect Immun 2002 70 : 427 433.
6. Robinson P, Atmar RL, Lewis DE White AC Jr. Granuloma cytokines in murine cysticercosis. Infect Immun 1997 65 : 2925 2931.
7. Villa OF Kuhn RE. Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena. Parasitology 1996 112 (Pt 6 561 570.
8. Stringer JL, Marks LM, White AC Jr. Robinson P. Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol 2003 183 : 532 536.
9. Pearce EJ MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002 2 : 499 511.
10. Brunet LR, Sabin EA, Cheever AW, Kopf MA Pearce EJ. Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells. Infect Immun 1999 67 : 3014 3018.
11. Rolfs A, Muhlschlegel F, Jansen-Rosseck R, et al. Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology 1995 45 (3 Pt 1 532 538.
12. Evans CA, Garcia HH, Hartnell A, et al. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 1998 66 : 4522 4525.
13. Rodrigues V Jr., de Mello FA, Magalhaes EP, Ribeiro SB Marquez JO. Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis. Braz J Med Biol Res 2000 33 : 1059 1063.
14. Uddin J, Garcia HH, Gilman RH, Gonzalez AE Friedland JS. Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis. J Immunol 2005 175 : 3273 3281.
15. ILAE. Guidelines for Epidemiologic studies on Epilepsy. Epilepsia 1993 34 : 592 596.
16. ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981 22 : 489 501.
17. ILAE. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989 30 : 389 399.
18. Otero E, Cordova S, Diaz F, Garcia-Teruel I Del Brutto OH. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Epilepsia 1989 30 : 569 572.
19. WHO. The World Health Report: 2001: Mental Health: New Understanding, new Hope. Geneva, WHO, 2001.
20. Preux PM Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005 4 : 21 31.
21. Burneo JG, Tellez-Zenteno J Wiebe S. Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res 2005 66 : 63 74.
22. Mac TL, Tran DS, Quet F, Odermatt P, Preux PM Tan CT. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 2007 6 : 533 543.
23. Forsgren L, Beghi E, Oun A Sillanpaa M. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005 12 : 245 253.
24. Peltola H. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin Infect Dis 2001 32 : 64 75.
25. Del Brutto OH, Roos KL, Coffey CS Garcia HH. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006 145 : 43 51.
26. Montano SM, Villaran MV, Ylquimiche L, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005 65 : 229 233.
27. Andriantsimahavandy A, Lesbordes JL, Rasoaharimalala B, et al. Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar. Trop Med Int Health 1997 2 : 741 746.
28. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L Preux PM. Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Epilepsia 2003 44 : 950 955.
29. Tran DS, Odermatt P, Le Oanh T, et al. Risk factors for epilepsy in rural Lao PDR: a case-control study. Southeast Asian J Trop Med Public Health 2007 38 : 537 542.
30. Cruz ME, Schantz PM, Cruz I, et al. Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol 1999 28 : 799 803.
31. Del Brutto OH, Santibanez R, Idrovo L, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 2005 46 : 583 587.
32. Gracia F, de Lao SL, Castillo L, et al. Epidemiology of epilepsy in Guaymi Indians from Bocas del Toro Province, Republic of Panama. Epilepsia 1990 31 : 718 723.
33. Jallon P. Epidemiology of epilepsies in Latin America L'EPIDEMIOLOGIE DES EPILEPSIES EN AMERIQUE LATINE. Epilepsies 1998 10 : 123 129.
34. Medina MT, Duron RM, Martinez L, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia 2005 46 : 124 131.
35. Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 2002 58 : 1256 1261.
36. Carpio A, Escobar A Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998 39 : 1025 1040.
37. Arpino C, Gattinara GC, Piergili D Curatolo P. Toxocara infection and epilepsy in children: a case-control study. Epilepsia 1990 31 : 33 36.
38. Nicoletti A, Sofia V, Mantella A, et al. Epilepsy and toxocariasis: a case-control study in Italy. Epilepsia 2008 49 : 594 599.
39. Critchley EM, Vakil SD, Hutchinson DN Taylor P. Toxoplasma, toxocara and epilepsy. Epilepsia 1982 23 : 315 321.
40. Woodruff AW, Bisseru B Bowe JC. Infection with animal helminths as a factor in causing poliomyelitis and epilepsy. Br Med J 1996 1 : 1576 1579.
41. Glickman LT, Cypess RH, Crumrine PK Gitlin DA. Toxocara infection and epilepsy in children. J Pediatr 1979 94 : 75 78.
42. Nicoletti A, Bartoloni A, Sofia V, et al. Epilepsy and toxocariasis: a case-control study in Burundi. Epilepsia 2007 48 : 894 899.
43. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W Schmutzhard E. Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 2008 102 : 1032 1038.
44. Akyol A, Bicerol B, Ertug S, Ertabaklar H Kiylioglu N. Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii. Seizure 2007 16 : 233 237.
45. Yariktas M, Demirci M, Aynali G, Kaya S Doner F. Relationship between Toxocara seropositivity and allergic rhinitis. Am J Rhinol 2007 21 : 248 250.
46. Newell ED, Vyungimana F Bradley JE. Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. Trans R Soc Trop Med Hyg 1997 91 : 525 527.
47. Kipp W, Kasoro S Burnham G. Onchocerciasis and epilepsy in Uganda. Lancet 1994 343 : 183 184.
48. Ovuga E, Kipp W, Mungherera M Kasoro S. Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda. East Afr Med J 1992 69 : 554 556.
49. Druet-Cabanac M, Boussinesq M, Dongmo L, Farnarier G, Bouteille B Preux PM. Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology 2004 23 : 144 149.
50. Katabarwa M, Lakwo T, Habumogisha P, Richards F Eberhard M. Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures? Am J Trop Med Hyg 2008 78 : 400 401.
51. Kipp W, Burnham G Kamugisha J. Improvement in seizures after ivermectin. Lancet 1992 340 : 789 790.
52. Trailovic SM Varagic VM. The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine. Vet Res Commun 2007 31 : 863 872.
53. Kong Y, Cho SY Kang WS. Sparganum infections in normal adult population and epileptic patients in Korea: a seroepidemiologic observation. Kisaengchunghak Chapchi 1994 32 : 85 92.
54. Lei T, Shu K, Chen X Li L. Surgical treatment of epilepsy with chronic cerebral granuloma caused by Schistosoma japonicum. Epilepsia 2008 49 : 73 79.
55. Preidler KW, Riepl T, Szolar D Ranner G. Cerebral schistosomiasis: MR and CT appearance. AJNR Am J Neuroradiol 1996 17 : 1598 1600.
56. Miyazaki I. Cerebral paragonimiasis. Contemp Neurol Ser 1975 12 : 109 132.
57. Higashi K, Aoki H, Tatebayashi K, Morioka H Sakata Y. Cerebral paragonimiasis. J Neurosurg 1971 34 : 515 527.
58. Betting LE, Pirani C Jr., de Souza QL, Damasceno BP Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol 2005 62 : 1008 1010.
59. Holodniy M, Almenoff J, Loutit J Steinberg GK. Cerebral sparganosis: case report and review. Rev Infect Dis 1991 13 : 155 159.
60. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002 2 : 751 762.
61. Nash TE, Singh G, White AC, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 2006 67 : 1120 1127.
62. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004 62 : 1934 1938.
63. Burnham G. Onchocerciasis. Lancet 1998 351 : 1341 1346.
64. Marin B, Boussinesq M, Druet-Cabanac M, Kamgno J, Bouteille B Preux PM. Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol 2006 22 : 17 20.
65. Duke BO, Vincelette J Moore PJ. The population dynamics of Onchocerca volvulus microfilariae during treatment with suramin and diethylcarbamazine. Tropenmed Parasitol 1976 27 : 133 144.
66. Chan CC, Nussenblatt RB, Kim MK, Palestine AG, Awadzi K Ottesen EA. Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology 1987 94 : 439 443.
67. Lee JC, Cho GS, Kwon JH, Shin MH, Lim JH Kim WK. Macrophageal/microglial cell activation and cerebral injury induced by excretory-secretory products secreted by Paragonimus westermani. Neurosci Res 2006 54 : 133 139.
68. Obwaller A, Duchene M, Walochnik J, Wiedermann G, Auer H Aspock H. Association of autoantibodies against small nuclear ribonucleoproteins (snRNPs) with symptomatic Toxocara canis infestation. Parasite Immunol 2004 26 : 327 333.
69. ura-Biegun A, Pituch-Noworolska A, Rewicka M, Mrozewicz B Noworolski J. Antistriational antibodies during Toxocara canis, Trichinella spiralis infections. Comp Immunol Microbiol Infect Dis 1998 21 : 101 106.
70. Rahima D, Tarrab-Hazdai R, Blank M, Arnon R Shoenfeld Y. Anti-nuclear antibodies associated with schistosomiasis and anti-schistosomal antibodies associated with SLE. Autoimmunity 1994 17 : 127 141.
71. Paganelli R, Ngu JL Levinsky RJ. Circulating immune complexes in onchocerciasis. Clin Exp Immunol 1980 39 : 570 575.
72. Levite M. Autoimmune epilepsy. Nat Immunol 2002 3 : 500.
73. Peltola JT, Haapala A, Isojarvi JL, et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 2000 109 : 712 717.
74. Palace J Lang B. Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 2000 69 : 711 714.
75. Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008 102 : 107 116.